What is the address of NEUROCHIRURGIE VANDEKERCKHOVE?

The registered office of NEUROCHIRURGIE VANDEKERCKHOVE is located at Rodonkstraat 38, 9030 Gent.

Is NEUROCHIRURGIE VANDEKERCKHOVE still active?

Not as usual. The CBE lists NEUROCHIRURGIE VANDEKERCKHOVE with legal situation “Vrijwillige ontbinding – vereffening”.

Is NEUROCHIRURGIE VANDEKERCKHOVE registered on Peppol?

No, NEUROCHIRURGIE VANDEKERCKHOVE is currently not registered on the Peppol network.

What is the enterprise number of NEUROCHIRURGIE VANDEKERCKHOVE?

The enterprise number of NEUROCHIRURGIE VANDEKERCKHOVE is BE0476503689.

When was NEUROCHIRURGIE VANDEKERCKHOVE founded?

NEUROCHIRURGIE VANDEKERCKHOVE was founded on 28 December 2001.

Who are the directors of NEUROCHIRURGIE VANDEKERCKHOVE?

According to the 2026 annual accounts, the directors of NEUROCHIRURGIE VANDEKERCKHOVE are: TOM VANDEKERCKHOVE.

Is NEUROCHIRURGIE VANDEKERCKHOVE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 28 December 2001; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did NEUROCHIRURGIE VANDEKERCKHOVE make in 2026?

NEUROCHIRURGIE VANDEKERCKHOVE posted a profit after taxes of € 296,853 in financial year 2026.

What is the revenue of NEUROCHIRURGIE VANDEKERCKHOVE?

As a small company, NEUROCHIRURGIE VANDEKERCKHOVE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -2,406.

NEUROCHIRURGIE VANDEKERCKHOVE (Private Limited) - Gent

Dossier NEUROCHIRURGIE VANDEKERCKHOVE, printed on 31 October 2026 from databakkes.be/en/0476503689/neurochirurgie-vandekerckhove. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2026

NEUROCHIRURGIE VANDEKERCKHOVE from Gent, company number BE0476503689, closed financial year 2026 with a result of € 296,853 after tax. For that financial year NEUROCHIRURGIE VANDEKERCKHOVE recorded a gross margin of € -2,406 and equity of € 3.5 million. Compared with financial year 2025, the result moved from € 362,869 to € 296,853. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 3.5 million

▲ 9% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 296,853

▼ 18% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 3.5 million

▲ € 3.5 million vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 3.5 million.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,725

▼ 25% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 89,710

▲ 61% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 277,423 Gross margin 2023: € 277,423 First fiscal year in the series	€ 468,687 Gross margin 2024: € 468,687 ▲ 69% vs 2023 (€ 277,423) Favourable step	€ 437,227 Gross margin 2025: € 437,227 ▼ 7% vs 2024 (€ 468,687) Unfavourable step	€ -2,406 Gross margin 2026: € -2,406 ▼ € 439,633 vs 2025 (€ 437,227) Unfavourable step	▼ € 439,633
Profit after taxes	€ 404,237 Profit after taxes 2023: € 404,237 First fiscal year in the series	€ 450,832 Profit after taxes 2024: € 450,832 ▲ 12% vs 2023 (€ 404,237) Favourable step	€ 362,869 Profit after taxes 2025: € 362,869 ▼ 20% vs 2024 (€ 450,832) Unfavourable step	€ 296,853 Profit after taxes 2026: € 296,853 ▼ 18% vs 2025 (€ 362,869) Unfavourable step	▼ 18%
Equity	€ 2,385,574 Equity 2023: € 2,385,574 First fiscal year in the series	€ 2,836,407 Equity 2024: € 2,836,407 ▲ 19% vs 2023 (€ 2,385,574) Favourable step	€ 3,199,275 Equity 2025: € 3,199,275 ▲ 13% vs 2024 (€ 2,836,407) Favourable step	€ 3,496,128 Equity 2026: € 3,496,128 ▲ 9% vs 2025 (€ 3,199,275) Favourable step	▲ 9%
Total debts	€ 225,543 Total debts 2023: € 225,543 First fiscal year in the series	€ 137,148 Total debts 2024: € 137,148 ▼ 39% vs 2023 (€ 225,543) Favourable step	€ 73,742 Total debts 2025: € 73,742 ▼ 46% vs 2024 (€ 137,148) Favourable step	€ 103,735 Total debts 2026: € 103,735 ▲ 41% vs 2025 (€ 73,742) Unfavourable step	▲ 41%
Cash	€ 113,163 Cash 2023: € 113,163 First fiscal year in the series	€ 57,031 Cash 2024: € 57,031 ▼ 50% vs 2023 (€ 113,163) Unfavourable step	€ 2,363 Cash 2025: € 2,363 ▼ 96% vs 2024 (€ 57,031) Unfavourable step	€ 3,516,332 Cash 2026: € 3,516,332 ▲ € 3.5 million vs 2025 (€ 2,363) Favourable step	▲ € 3.5 million
Land & buildings	€ 89,672 Land & buildings 2023: € 89,672 First fiscal year in the series	€ 46,500 Land & buildings 2024: € 46,500 ▼ 48% vs 2023 (€ 89,672) Unchanged	€ 37,200 Land & buildings 2025: € 37,200 ▼ 20% vs 2024 (€ 46,500) Unchanged	€ 30,219 Land & buildings 2026: € 30,219 ▼ 19% vs 2025 (€ 37,200) Unchanged	▼ 19%
Retained profit	€ 2,376,646 Retained profit 2023: € 2,376,646 First fiscal year in the series	€ 2,827,479 Retained profit 2024: € 2,827,479 ▲ 19% vs 2023 (€ 2,376,646) Favourable step	€ 3,190,347 Retained profit 2025: € 3,190,347 ▲ 13% vs 2024 (€ 2,827,479) Favourable step	€ 3,487,200 Retained profit 2026: € 3,487,200 ▲ 9% vs 2025 (€ 3,190,347) Favourable step	▲ 9%
Dividend	€ 105,263 Dividend 2023: € 105,263 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 105,263) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 2,611,117 Balance sheet total 2023: € 2,611,117 First fiscal year in the series	€ 2,973,554 Balance sheet total 2024: € 2,973,554 ▲ 14% vs 2023 (€ 2,611,117) Unchanged	€ 3,280,883 Balance sheet total 2025: € 3,280,883 ▲ 10% vs 2024 (€ 2,973,554) Unchanged	€ 3,605,490 Balance sheet total 2026: € 3,605,490 ▲ 10% vs 2025 (€ 3,280,883) Unchanged	▲ 10%

Key figures of NEUROCHIRURGIE VANDEKERCKHOVE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to NEUROCHIRURGIE VANDEKERCKHOVE?

What happened at NEUROCHIRURGIE VANDEKERCKHOVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

NEUROCHIRURGIE VANDEKERCKHOVE is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

Jun 30, 2026 New annual accounts for financial year 2026: profit of € 296,853 (▼ 18% vs 2025). Source: NBB ↗
2026 TOM VANDEKERCKHOVE became a director. NBB
Dec 28, 2001 Start of the company according to the CBE. KBO

In short

From € 404,237 profit in 2023 to € 296,853 profit in 2026.

Paid € 441,171 in corporate taxes since 2023.

Best year ever: 2024, with € 450,832 profit.

Paid out € 105,263 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

TOM VANDEKERCKHOVE

NEUROCHIRURGIE VANDEKERCKHOVE

Behind NEUROCHIRURGIE VANDEKERCKHOVE is TOM VANDEKERCKHOVE.

Directors

According to the 2026 annual accounts

TOM VANDEKERCKHOVE

Liquidator

since 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Rodonkstraat 38

9030 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.503.689
VAT number: BE 0476.503.689
Registered office: Rodonkstraat 38, 9030 Gent
Names & denominations: NEUROCHIRURGIE VANDEKERCKHOVE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Vrijwillige ontbinding – vereffening
Start date: 28 December 2001
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗